ACROBiosystems unveils four-day antibody validation service for AI-driven drug discovery
AI Summary- ACROBiosystems launched ACRO AIx, CHO-Direct and GlobalLifeShip for AI-driven drug discovery.
- Four days is the stated minimum turnaround from antibody sequence submission to affinity data.
- ACRO AIx includes products, tools, validation and data connections; GlobalLifeShip offers cross-border logistics.